Entity

FDA

FDA — U.S. Food and Drug Administration. The U.S. regulator that approves drugs, medical devices, and food safety.

As of 24 Oct 2026Last evidence 23 Oct 2026

What is happening now

  • FDA grants traditional approval for pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph for unresectable or metastatic TMB-H solid tumors with updated indication

    Reported claim · first reported 22 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices

    Reported claim · first reported 22 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • FDA Advisory No.2026-1599 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “DIY HEALTH CARE ACULIFE I-DOC ELECTRO-ACUPUNCTURE DEVICE”

    Reported claim · first reported 21 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

  • Samsung Bioepis wins FDA Fast Track for 1st anticancer drug candidate

    Reported claim · first reported 21 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • FDA solidifies stance on mobile apps, software used with prescription drugs in final guidance

    Reported claim · first reported 20 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

All 9 events and claims involving FDA

What changed

  • Attention Steady: 145 mentions on 24 Oct 2026, against 135 on 3 Oct 2026 (+7%).
  • State Last recorded change: coverage state went from steady to rising on 24 Oct 2026 (3 changes recorded since 13 Oct 2026).
  • Claims No claim first reported since 23 Oct 2026.

How well we know this

2,564 documents · 228 publishers · 35% contain a typed assertion · last evidence 23 Oct 2026

  • Gap: assertion coverage 0.354: about 65% of mentions carry no typed assertion
  • Gap: 4 receipts withheld: no source link (the same rule the topic record applies)

In this snapshot’s daily coverage:

Reported alongside FDA

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

United StatesAITrump
  • Drug Administration · 862 shared documents · no page of its own yet
  • U.s. Food · 339 shared documents · no page of its own yet
  • United States · 326 shared documents
  • AI · 311 shared documents
  • Clinical Trials · 303 shared documents · no page of its own yet
  • Clinical Trial · 290 shared documents · no page of its own yet
  • Fda-Approved · 227 shared documents · no page of its own yet
  • Public Health · 223 shared documents · no page of its own yet
  • Trump · 204 shared documents
  • Adverse Events · 163 shared documents · no page of its own yet

Story momentum

Steady

The word compares 145 mentions on 24 Oct 2026 with 135 on 3 Oct 2026 (+7%); a change of less than 8% either way reads Steady.

Daily mentions +138% from 9 Sept 2026 to 24 Oct 2026, between 10 and 171 a day

How often tracked coverage mentions FDA, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about FDA yet. Ask about FDA

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

On the desk: Health & Bio Desk

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4 returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name fda.

{
  "name": "fda",
  "label": "FDA",
  "asOf": "2026-10-24",
  "mentions": 145,
  "domains": 27,
  "node": {
    "id": "sb:e/1ccaf7a7b68e32af55cbc6a4",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4",
    "knowledgeCutoff": "2026-10-24T17:26:22.831487+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "steady",
  "history": {
    "since": "2026-10-13T13:19:04.891662+00:00",
    "changes": 3
  },
  "whereFrom": {
    "level": "counts",
    "label": "145 mentions across 27 domains",
    "children": [
      {
        "level": "reports",
        "label": "5 reports drawn on this page, each with its link",
        "children": {
          "count": 5,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "27 coverage domains",
        "children": {
          "count": 18,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 140 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving FDA

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

  • FDA grants traditional approval for pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph for unresectable or metastatic TMB-H solid tumors with updated indication

    Reported claim · first reported 22 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    reported by two

  • STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices

    Reported claim · first reported 22 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    single source

  • FDA Advisory No.2026-1599 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “DIY HEALTH CARE ACULIFE I-DOC ELECTRO-ACUPUNCTURE DEVICE”

    Reported claim · first reported 21 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • Samsung Bioepis wins FDA Fast Track for 1st anticancer drug candidate

    Reported claim · first reported 21 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    reported by two

  • FDA solidifies stance on mobile apps, software used with prescription drugs in final guidance

    Reported claim · first reported 20 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

    corroborated

  • FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

    Reported claim · first reported 20 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

    single source

  • FDA grants accelerated approval to dostarlimab for locally advanced rectal cancer

    Reported claim · first reported 19 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

    corroborated

  • Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System

    Reported claim · first reported 19 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

    single source

  • fda concerns unapproved glp-1 drugs weight loss 2026

    Reported claim · first reported 18 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

    could not check

Walk the record from FDA

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

FDA

Entity.

Evidence
2,564 documents · 228 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 6 Apr 2026, last seen 23 Oct 2026
Measured
35% of mentions say something specific about it; the rest only name it
As of
24 Oct 2026
19 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (9)

  • Corroborated: Reported by three or more sources that did not copy each other.
  • Reported by two: Reported by two sources that did not copy each other.
  • Single source: Reported by one source so far.
  • Could not check: We could not count this claim's sources, so we do not say how well it is supported.

Situations it is named in (0)

none on file at this cutoff

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names FDA, newest first. Open any row to follow it to the original article.

1 more headline counted but not shown: no source link on file

Evidence tiers: primary source = an official public record · attributed = a named outlet, receipt linked · lead = observed, not yet receipted.

Markets materially about FDA

Markets whose question is about FDA or names it as a party. Each row says how the market relates to FDA and why. Prices are the market’s own, cited with the venue.

What it connects to

Related records.

Recorded history

  • 24 Oct 2026

    coverage state changed: steady to rising

    Previous state held since 18 Oct 2026

  • 18 Oct 2026

    coverage state changed: rising to steady

    Previous state held since 15 Oct 2026

  • 15 Oct 2026

    coverage state changed: steady to rising

    Previous state held since 12 Oct 2026

3 changes recorded since 13 Oct 2026, newest first.

Ask about FDAWatch FDA

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 24 Oct 2026.